You are here

Calliditas Therapeutics

Smaller Biopharma M&A on Upswing, Deals Expected to Continue Through 2024

BioSpace

Fri, 05/31/24 - 10:59 am

Numab Therapeutics

Calliditas Therapeutics

Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics

BioSpace

Tue, 05/28/24 - 10:34 pm

Calliditas Therapeutics

Calliditas starts Phase II trial for rare kidney disease therapy

Clinical Trials Arena

Thu, 11/30/23 - 10:04 am

Calliditas Therapeutics

clinical trials

Alport syndrome

Catalysts ahead for the smaller players

EP Vantage

Wed, 12/21/22 - 11:19 am

BioXcel Therapeutics

Calliditas Therapeutics

Esperion Therapeutics

Nektar Therapeutics

Oramed Pharmaceuticals

Pliant Therapeutics

Selecta Biosciences

Swedish Orphan Biovitrum

Vera Therapeutics

Viking Therapeutics